Tempus AI, Inc. (NASDAQ:TEM) CFO James William Rogers Sells 1,468 Shares

Tempus AI, Inc. (NASDAQ:TEM) CFO James William Rogers sold 1,468 shares of Tempus AI stock in a transaction dated Monday, December 16th. The shares were sold at an average price of $40.23, for a total transaction of $59,057.64. Following the transaction, the chief financial officer now directly owns 229,812 shares of the company’s stock, valued at approximately $9,245,336.76. This trade represents a 0.63 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink.

James William Rogers also recently made the following trade(s):

• On Wednesday, December 11th, James William Rogers sold 83,025 shares of Tempus AI stock. The shares were sold at an average price of $42.30, for a total transaction of $3,511,957.50.

Tempus AI Trading Down 12.0 %

Shares of TEM stock opened at $34.29 on Thursday. The business has a 50 day moving average of $52.24. Tempus AI, Inc. has a 52 week low of $22.89 and a 52 week high of $79.49. The company has a debt-to-equity ratio of 8.17, a current ratio of 2.69 and a quick ratio of 2.55.

Wall Street Analyst Weigh In

Several analysts recently weighed in on TEM shares. Piper Sandler restated a “neutral” rating and issued a $70.00 price target (up previously from $40.00) on shares of Tempus AI in a research note on Tuesday, November 12th. Stifel Nicolaus cut Tempus AI from a “buy” rating to a “hold” rating and increased their target price for the stock from $45.00 to $65.00 in a research note on Monday, November 11th. Loop Capital lifted their price target on Tempus AI from $48.00 to $57.00 and gave the stock a “buy” rating in a research report on Tuesday, October 15th. Bank of America increased their price objective on shares of Tempus AI from $52.00 to $54.00 and gave the company a “neutral” rating in a research report on Friday, December 13th. Finally, Guggenheim began coverage on shares of Tempus AI in a report on Monday, December 9th. They issued a “buy” rating and a $74.00 target price for the company. Three research analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, Tempus AI has a consensus rating of “Moderate Buy” and a consensus price target of $56.00.

Institutional Investors Weigh In On Tempus AI

A number of large investors have recently added to or reduced their stakes in TEM. First Horizon Advisors Inc. bought a new stake in shares of Tempus AI during the 3rd quarter valued at about $30,000. Sandia Investment Management LP bought a new stake in Tempus AI during the second quarter valued at approximately $136,000. Vestor Capital LLC bought a new stake in Tempus AI during the third quarter valued at approximately $153,000. Stifel Financial Corp purchased a new stake in Tempus AI during the third quarter valued at approximately $218,000. Finally, IQ EQ FUND MANAGEMENT IRELAND Ltd bought a new position in Tempus AI in the third quarter worth approximately $258,000. Institutional investors own 24.22% of the company’s stock.

Tempus AI Company Profile

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.